Quantcast

Latest Immunosuppressants Stories

2014-12-02 00:21:56

- Update on complete remissions with personalized cell therapy CTL019 in patients with relapsed/refractory acute lymphoblastic leukemia EAST HANOVER, N.J., Dec.

2014-12-01 08:29:53

DALLAS, December 1, 2014 /PRNewswire/ -- ReportsnReports.com adds EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 market research on the autoimmune

2014-11-25 16:27:52

Study Met All Primary Endpoints Against Stelara® (ustekinumab) and Placebo THOUSAND OAKS, Calif. and LONDON, Nov.

2014-11-24 16:24:42

However, Platform Injectables Continue to Represent the Majority of Recent MS Prescriptions, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.

2014-11-24 12:26:31

U.S. Court of Appeals for the Federal Circuit Concurrently Affirms Denial of Antares Pharma's Motion to Prohibit the Marketing of Rasuvo CHICAGO, Nov.

2014-11-24 08:27:22

Right the Wrong Campaign seeks to educate Canadians on how a government approved drug left them with severe birth defects that challenge their lives to this day MONTREAL, Nov.

2014-11-24 04:20:44

CHENÔVE, France, November 24, 2014 /PRNewswire/ -- - The needle-free injection with ZENEO(R) Methrotrexate produces similar blood levels to the

2014-11-19 23:01:15

ReportsnReports.com adds Rheumatoid Arthritis Global Clinical Trials Review H2 2014 to its store.

2014-11-19 12:29:10

EVOLVE II Trial Represents the First Successful U.S. Pivotal Trial of a Bioabsorbable Polymer Stent MARLBOROUGH, Mass., Nov. 19, 2014 /PRNewswire/ -- In the first successful U.S.


Word of the Day
gubbings
  • The parings of haberdine; also, any kind of fragments.
The word 'gubbings' is a variant of the word 'gobbon', meaning 'a portion, gobbet.'